NANOPHASE TECHS CORP - NANX STOCK NEWS

Nanophase Technologies (OTCQB: NANX) has announced its Third Quarter 2024 financial results release and conference call schedule. The company will release financial results after market close on October 30, 2024, followed by an investor conference call on October 31, 2024 at 1:00 p.m. CDT. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton discussing financial results and providing business updates. The company specializes in mineral-based healthcare solutions for beauty and life science categories, focusing on skin protection and medical diagnostics.

Nanophase Technologies (OTCQB: NANX) reported record financial results for Q2 2024, with revenue reaching $13 million, a 10% increase from Q2 2023. The company's Solésence subsidiary saw a 44% year-over-year revenue increase to $11.2 million. Net income for Q2 was $856,000, a 157% increase from the same period last year.

For the first half of 2024, Nanophase reported revenue of $22.9 million, a 7% increase from H1 2023. Net income for H1 2024 was $1.7 million, compared to a net loss of $0.8 million in H1 2023. The company also won its third consecutive Cosmopack North America Formulation Award for its Lip Oil SPF 40+ product.

Nanophase Technologies (OTCQB: NANX), a leader in mineral-based health care solutions, has announced its Second Quarter 2024 financial release and conference call details. The company will release its financial news after market close on Tuesday, August 6, 2024, followed by an investor conference call on Wednesday, August 7, 2024, at 11:00 a.m. CDT.

The call will feature Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer. Participants can register for the call to receive dial-in information and a personalized PIN. A listen-only webcast and replay option will also be available through the company's website.

Nanophase Technologies specializes in minerals-based solutions for beauty and life science categories, as well as advanced materials applications, leveraging patented technologies to create unique performance products.

Solésence Beauty Science, a subsidiary of Nanophase Technologies, has won the Cosmopack North America Formulation Award for the third consecutive year. Their winning product, Lip Oil SPF 40+ featuring Solésence Kleair™, bridges the gap between skincare and makeup, offering a twelve-shade range of mineral-based, broad-spectrum SPF protection.

The formula utilizes sustainably produced ingredients and is designed to prevent premature aging and reduce pollution-induced free radicals. This achievement follows their 2023 win for Natural Glow Face Oil SPF 40+ and 2022 win for Multi-Cultural Magic SPF 50+. Solésence's success highlights their commitment to innovation in skin health products across skincare and makeup categories.

Solésence Beauty Science, a subsidiary of Nanophase Technologies, will join other winners of the Chicago Innovation Awards to ring the Nasdaq Opening Bell on July 9, 2024. This event highlights innovation in the Chicago region. Solésence's award-winning Kleair™ technology optimizes zinc oxide for enhanced skin health and meets global purity standards. Leaders Jess Jankowski and Kevin Cureton will represent Solésence at the event. The 2023 Chicago Innovation Awards winners span across various industries and include companies like Abbott, Argonne National Laboratory, and VOCEL.

Nanophase Technologies (NANX) reported record first-quarter results with $9.9 million in revenue and $0.9 million in profit. The company resolved all ongoing litigation with BASF, setting the stage for further growth. Solésence product revenue contributed significantly to the revenue increase, with a 4% rise from the previous year. Gross profit saw a substantial 57% increase, while net income turned positive at $0.9 million compared to a loss in the previous year. The company's successful start to 2024 was highlighted by three consecutive profitable months and the winning of the Allē Award for the second year in a row. Nanophase anticipates a breakthrough year with continued growth in the Solésence business and a focus on building the company's brand.

Nanophase Technologies (NANX) announces its First Quarter 2024 Financial Release and Conference Call Details. The company, known for mineral-based health care solutions in beauty and life sciences, will release financial news on April 23, 2024, followed by an investor conference call on April 24. The call will discuss financial results and provide business updates with participation from the President & CEO and the Chief Operating Officer.

Nanophase Technologies (NANX) resolves litigation with BASF, focusing on growth in API and Solésence finished products business.

Nanophase Technologies (NANX) reported $37.3 million in full-year revenue, closed a $6 million financing deal, and won the 2024 Cosmetics and Toiletries Allē Award. Despite supply chain challenges affecting profitability in Q3 and Q4 of 2023, the company remains optimistic about its future. Revenue for Q4 was $8 million, with a net loss of $2.1 million. Solésence revenue increased by 9% to $25.2 million, while Personal Care Ingredients revenue decreased by 17% to $9.3 million. Advanced Materials revenue also saw a decline. The company highlighted operational improvements and strategic initiatives to enhance efficiency and performance in 2024.